Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for…
Disc will obtain exclusive rights to MWTX-003 and other novel anti-TMPRSS6 antibodies in the United States, Europe and other territories excluding Greater China and certain other…